Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
暂无分享,去创建一个
A. Fanjul | M. Pfahl | Seong-Jin Kim | S. Kim | G. Salbert | F. J. Piedrafita | X. P. Lu | P. Tran | X. Lu
[1] K. Flanders,et al. Interactions between retinoids and TGF beta s in mouse morphogenesis. , 1992, Development.
[2] K. Umesono,et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.
[3] M. Pfahl,et al. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.
[4] Philippe Kastner,et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.
[5] C. Glass,et al. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.
[6] R. Evans,et al. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. , 1991, Trends in genetics : TIG.
[7] P. Scardino,et al. Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. , 1991, Molecular endocrinology.
[8] M. Nakajima,et al. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[10] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[11] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[12] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[13] K. Yamamoto,et al. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.
[14] E. Ruoslahti,et al. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.
[15] M. Sporn,et al. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia , 1990, The Journal of experimental medicine.
[16] R. Evans,et al. Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.
[17] M. Shago,et al. Identification of a novel isoform of the retinoic acid receptor gamma expressed in the mouse embryo , 1990, Molecular and cellular biology.
[18] P. Gruppuso,et al. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[19] E. Appella,et al. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Chambon,et al. Nuclear receptors enhance our understanding of transcription regulation. , 1988, Trends in genetics : TIG.
[21] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[22] A. Schönthal,et al. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters , 1988, Cell.
[23] R. Tarone,et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. , 1988, The New England journal of medicine.
[24] M. Sporn,et al. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. , 1988, The Journal of biological chemistry.
[25] P. Chambon,et al. Identification of a second human retinoic acid receptor , 1988, Nature.
[26] V. Giguère,et al. Identification of a receptor for the morphogen retinoic acid , 1987, Nature.
[27] M. Karin,et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.
[28] H. Moses,et al. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. , 1986, Cancer research.
[29] M. Steiner,et al. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. , 1992, Molecular endocrinology.
[30] J. Mead,et al. Effects of TGF-beta s in the liver: cell proliferation and fibrogenesis. , 1991, Ciba Foundation symposium.
[31] M. Sporn,et al. Transforming Growth Factor , 1990 .
[32] J. Massagué,et al. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.
[33] M. Sporn,et al. Increased secretion of type beta transforming growth factor accompanies viral transformation of cells , 1985, Molecular and cellular biology.